Sveriges mest populära poddar

Pharmaceutical Executive Daily: CVS Health to Offer Zepbound and Foundayo

3 min•28 maj 2026

In today’s Pharmaceutical Executive Daily, an FDA advisory committee weighs recommendations for the composition of the 2026–2027 Covid-19 vaccines, CVS Health restores coverage for Eli Lilly’s Zepbound while adding the company’s newly approved obesity pill Foundayo, and experts discuss how treatment expectations are evolving in lupus care.

Fler avsnitt av Pharmaceutical Executive

Pharmaceutical Executive Daily: The Changing Reality of Pharmaceutical Commercialization

7 juli•3 min

Pharmaceutical Executive Daily: The Medicare GLP-1 Bridge

1 juli•3 min

Pharmaceutical Executive Daily: FDA Names Seven Participants to Precheck Program

30 juni•3 min

Pharmaceutical Executive Daily: Ipsen Enters Merger Agreement to Acquire Kartos Therapeutics

29 juni•4 min

Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer

25 juni•3 min

Pharmaceutical Executive Daily: Eli Lilly and Abbisko Announce Drug Development Collaboration

24 juni•3 min

Pharmaceutical Executive Daily: FDA Pilot Targets Faster Early-Stage Drug Trial Starts

23 juni•4 min

Pharmaceutical Executive Daily: AbbVie Acquires Apogee Therapeutics for $10.9 Billion

22 juni•3 min

Pharmaceutical Executive Daily: FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1010

19 juni•4 min

Pharmaceutical Executive Daily: FDA Approves Utebzi and Capvaxive

18 juni•4 min

Pharmaceutical Executive med Pharmaceutical Executive Podcast finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.